Strategic Acquisition Pace Life Sciences recently acquired Meridian BioGroup, expanding its capabilities in quality, compliance, validation, and regulatory consulting to biopharma and biotech clients, creating cross-sell opportunities across contract development and manufacturing services.

Full Suite Offering Leverage the integrated services including CMC development, CTM manufacturing, regulatory compliance, consulting, and facility support to position cross-service proposals for clients seeking end-to-end solutions from development through commercialization.

Regulatory Expertise Target customers needing FDA-regulated quality systems, validation, and regulatory support, emphasizing Pace Life Sciences’ strength in ensuring compliant operations across multiple CDMO sites and GMP analytical labs.

Mid-Market Focus With a customer base likely in the mid-market tier (given revenue and employee size), tailor value propositions around scalable, cost-efficient regulatory and manufacturing support for growing biotech and gene therapy programs.

Digital & Global Reach Capitalize on a nationwide network of FDA-registered facilities and analytical labs to offer geographically flexible engagement models, accelerate time-to-clinic, and support clients seeking rapid regulatory and manufacturing readiness.